Radiological Assessment of Total Knee Arthroplasty

Mulpur, Praharsha; Hippalgaonkar, Kushal; Reddy, A V Gurava

doi:10.1007/978-981-16-8591-0_9

Cited by 1 publication

(1 citation statement)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Many studies on revision TAA report similar constraints, particularly within TAA, 13 but also within other forms of TJA. 4,7,11,16,22,30,33 We used only INBONE II for revision TAA, and although the INBONE II system was not designed specifically for revision TAA, it has been widely used for revision cases.…”

Section: Limitationsmentioning

confidence: 99%

Revision Total Ankle Arthroplasty Using the INBONE II System

Wu,

Anastasio,

Lee

et al. 2024

Foot Ankle Int.

View full text Add to dashboard Cite

Background: The utilization of total ankle arthroplasty (TAA) for managing severe ankle osteoarthritis has become increasingly common, leading to a higher occurrence of revision TAA procedures because of failure of primary TAA. This study aims to examine the clinical results associated with revision TAA using the INBONE II system. Given the growing number of TAA revision procedures and a focus on motion-preserving salvage options, we evaluated our early experience with revision TAA. Methods: A retrospective analysis was conducted on a group of 60 presumed noninfected patients who underwent revision TAA with the INBONE II system. Detailed information was collected on patient demographics, implant characteristics, concurrent procedures, and complications. The implant survival was estimated using Kaplan-Meier analysis. Results: The study revealed high complication rates but generally fair clinical outcomes for revision TAA using the INBONE II system. Complications were observed in 22 patients (36.7%), including persistent pain (n = 6), nerve injury/impingement (n = 5), infection (n = 3), fracture (n = 3), implant failure (n = 3), impaired wound healing (n = 2), and osteolysis (n = 3). The 3-year survivorship rate from reoperation was 92.0% (82.7%-100.0%) whereas the 3-year survivorship rate from major complications was 90.4% (80.8%-100.0%). Conclusion: We report high complication rates but generally fair clinical results for revision TAA utilizing the INBONE II system. Level of Evidence: Level IV, retrospective case series study.

show abstract